
Therapeutic Segment
Anticoagulant
CAS No.
366789-02-8
Regulatory Filing
USDMF, CEP
Development Status
DMF Filed
Molecule Type
Small Molecule
Mechanism of Action
Rivaroxaban is a selective inhibitor of Fxa. By inhibiting FXa, rivaroxaban decreases thrombin generation and thrombus development.